Effects of Targeted Delivery of Metformin and Dental Pulp Stem Cells on Osteogenesis via Demineralized Dentin Matrix under High Glucose Conditions

Xianling Gao,Wei Qin,Lingling Chen,Wenguo Fan,Tao Ma,Abraham Schneider,Mengyao Yang,Obinna N. Obianom,Jiayao Chen,Michael D. Weir,Yan Shu,Liang Zhao,Zhengmei Lin,Hockin H. K. Xu

DOI: https://doi.org/10.1021/acsbiomaterials.0c00124

2020-01-01

ACS Biomaterials Science & Engineering

Abstract:High glucose condition inhibited osteoblast differentiation could be a main mechanism contributing to the decreased bone repair associated with diabetes. Metformin, a widely prescribed antidiabetic drug, was shown to have osteogenic properties in our previous study. Transplanted mesenchymal stromal cells (MSCs) may differentiate into osteoblasts and promote bone regeneration. Our study aimed to combine the benefits of metformin and MSCs transplantation on osteogenesis in high glucose conditions. We developed demineralized dentin matrix (DDM) as a carrier to target deliver metformin and dental pulp-derived MSCs (DPSCs). We collected clinically discarded teeth, isolated DPSCs from the dental pulp, and prepared the DDM from the dentin. The DDM was observed by scanning electron microscopy and was found to have well-distributed tubes. Then, metformin was loaded into the DDM to form the DDM–Met complex (DDM–Met); DDM–Met released metformin at a favorable concentration. The DPSCs seeded with the DDM–Met in a high glucose medium showed satisfactory attachment and viability together with increased mineralization and upregulated osteogenesis-related genes, including alkaline phosphatase (ALP), osteocalcin (OCN), runt-related transcription factor 2 (Runx2), and osteopontin (OPN). A possible mechanism of the enhanced osteogenic differentiation of DPSCs was explored, and the adenosine 5′-monophosphate (AMP)-activated protein kinase (AMPK) pathway was found to play a role in the enhancement of osteogenesis. DDM–Met appeared to be a successful metformin and DPSC carrier that allowed for the local delivery of metformin and DPSCs in high glucose conditions. DDM–Met–DPSC construct has promising prospects to promote osteogenesis and enhance the much-needed diabetic bone regeneration.